PBAC suggested a future submission focus on patients with heart disease, type 2 diabetes, or multiple high-risk factors such as high blood pressure, cholesterol, or kidney disease
one 68-week, randomized, double-blind, placebo withdrawal trial
Supports Detoxification: Enhances liver function and helps the body eliminate toxins effectively
The GLP-1 drugs are the latest class to show a benefit in patients, this time with OSA, but like other tools have nontrivial side effects, cost concerns, and patient persistence issues that balance out the headline benefits. The size of the underlying patient populations, which are expected to surpass 1.3 billion globally by 2050, as well as the under penetration of CPAP treatment, which Andrew ballparks at 15% or less in many markets, reinforces the analysts argument
It was suspected that there would also be hormonal regulation of metabolism, and after the discovery of insulin, researchers began to think about incretins, substances that could regulate insulin secretion similar to the regulation of exocrine function by excretins [2]
![PDF] The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review](https://figures.semanticscholar.org/0fd860de34d08549f35b05af15ce08d651210045/4-Figure1-1.png)
